cas 915087-32-0|| where to buy 4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

Produktname:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM329948-100mg	in stock	ưƞư
CM329948-250mg	in stock	Ţƞư
CM329948-1g	in stock	ƞƄź
CM329948-5g	1-2 Weeks	ưǯȎư

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 915087-32-0 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:915087-32-0; Molekulare Formel:C12H14FN3O; Schmelzpunkt:-; SMILES-Code:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F; Dichte:

: Katalognummer:CM329948; Molekulargewicht:235.26; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Enzalutamide; Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.